When considering a potential switch, the FDA is tasked with weighing the benefits of enhanced access against the incremental risks greater access will pose. In doing so, the FDA will generally consider the efficacy and safety profile of a drug based upon the studies conducted to gain Rx approval, as well as the clinical knowledge gained from first-hand experience of the product usage on the Rx marketplace. In addition, the FDA requires additional studies with consumers demonstrating that they can use the product safely in an OTC setting without third-party intervention. (more…)
Transparency, ingredients, and clear labeling are important to consumers of nutritional supplements and probiotics. These are also substantial to reputable manufacturers in these markets looking to educate consumers on product benefits and to distance their brands from products on the market with less science supporting their claims and benefits.
In January 2017, the Council for Responsible Nutrition and the International Probiotics Association collaboratively published “Best Practice Guidelines for Probiotics” as a proactive set of voluntary, scientifically-based guidelines to encourage responsible production and marketing of dietary supplements and functional foods that contain probiotics. (more…)
The industrial and institutional cleaning wipes market presents opportunities for companies to tap into this growing segment. All major end-use segments are expected to increase consumption of wipes, reflecting the need for superior cleaning products and to maintain clean and healthy facilities. The ease of use and convenience that wipes offer end users will contribute to future growth across all end-use segments, largely for general-purpose wipes. End-use segments, such as healthcare facilities, food service, and schools and universities, will continue to emphasize the importance of clean surfaces and hands in order to minimize germs and illness at their facilities. Wipes are expected to play a key role in this goal.
There has been a fair amount of research on the therapeutic effects of light technologies for a broad range of conditions, such as allergies, wound healing, fibromyalgia, neuropathy, and even to help minimize the side effects of chemotherapy and radiation treatments for cancer patients. Polarized medical light has been found in studies to be particularly effective for pain management, wound healing, and other conditions because of its ability to penetrate deep into the body and stimulate healing at the cellular level. As such technologies are studied and more devices are brought to market, these products could have an impact on traditional OTC drugs. Kline’s upcoming Self-care Devices: U.S. Market Analysis and Opportunities study will examine the size, growth, and impact such devices have and are expected to have in the future on traditional OTCs across various categories, including acne, allergy, anti-itch, cold sores, hair regrowth, pain, and sleep aids, among others. (more…)
Kline is now working on our largest I&I market study, Janitorial and Housekeeping Cleaning Products: U.S. Market Analysis and Opportunities, and we have uncovered several trends that will significantly change the market in the near future.
Rising labor costs with minimum wage increases are driving industrial and institutional (I&I) end users to cut back on costs, which includes less spending on cleaning chemicals and/or reduced frequency of performing certain cleaning tasks. There is also some growth in private-label cleaning chemicals as end users seek low prices and value from their jan/san products. There are cycles of outsourcing and doing the work in-house among end users, such as office buildings and industrial parks. (more…)
The U.S. OTC market has enjoyed solid momentum in recent years, increasing far beyond the typical 2% to 3% annual growth it used to experience. Strong advertising and promotional investments, several new products, and Rx-to-OTC switch brands, as well as the steady distribution of major brands that had been off the market for several years, have helped propel the market beyond regular growth.
Lately, we’ve seen several alternative sources of competition for traditional OTCs that are emerging. Self-care devices, which have been around for many years in the beauty realm, are now entering OTC categories. TENS technology is being used in the topical analgesics market, while low light technology is seen in new devices that treat hair loss, cold sores, and even allergies. Bayer, which markets Aleve Direct Therapy TENS device for lower back pain, and Sanofi, with its Icy Hot TENS device, are among the new market entrants in this space. (more…)
Last week, Kline attended the ISSA Interclean Show in Chicago, and it was great to see so many exhibitors and clients. It seems that the industry is starting to catch up to technology with the release of floor care robots. Sealed Air Taski’s Intellibot Aerobot 1850 and Minuteman’s Autonomy Roboscrub machine were of the more prevalent robots roaming around and cleaning floors. In addition to being a first-time exhibitor at the show, the Autonomy by Brain Corp. product won the “Innovation of the Year” award from ISSA. The company’s concept is to further the knowledge towards autonomous, machine-learning systems. (more…)
In the presence of many infectious diseases, consumers understand the important role hand hygiene plays in maintaining good health. The public has become more aware about frequent hand washing as a tool to avoid viruses and the spread of germs, which has resulted in an increased frequency of handwashing. Sales of professional-use hand care products surpass other professional cleaning chemicals, growing at 3.6% in 2015 to nearly $1.5 billion at the end-user level.
As of early August 2016, new FDA regulations took effect requiring e-cigarette manufacturers to prove their products meet public health standards. These new rules apply to manufacturers that began selling e-cigarettes before February 2007 and will now need to obtain FDA marketing authorization for existing and new e-cigarettes in order to continue selling these products. As a result, the cost of doing business just increased significantly for marketers in this industry. (more…)
Driven by the market return of popular OTC brands from Johnson & Johnson and GlaxoSmithKline, as well as the success of several Rx-to-OTC switch brands, the U.S. OTC market increases by a solid 4% in 2015, reveals our recently published Nonprescription Drugs USA report.
In October 2015, Johnson & Johnson announced that the FDA approved the reopening of the Fort Washington, PA, plant that had been shuttered since May 2010. Johnson & Johnson’s key brands, including Tylenol Arthritis Pain and Tylenol 8 Hour, are re-launched in 2015, supporting overall sales growth of the OTC drugs market. Steady distribution of Zyrtec and other key brands from the market leader, Johnson & Johnson, help propel sales in the OTC market. (more…)